Differential modulation and prognostic values of immune-escape genes in uveal melanoma

Prognostic value of DcR3 in solid tumors: A meta-analysis

(2018) Hua Ge et al.   CLINICA CHIMICA ACTA

Galectin-9 Expression Predicts Favorable Clinical Outcome in Solid Tumors: A Systematic Review and Meta-Analysis

(2018) Xiaoxiang Zhou et al.   Frontiers in Physiology

PD-L1 expression in tumor metastasis is different between uveal melanoma and cutaneous melanoma

(2017) Asad Javed et al.   Immunotherapy

Melanoma subtypes demonstrate distinct PD-L1 expression profiles

(2017) Genevieve J Kaunitz et al.   LABORATORY INVESTIGATION

Identification of novel chemotherapeutic strategies for metastatic uveal melanoma

(2017) Paolo Fagone et al.   Scientific Reports

Uveal melanoma: From diagnosis to treatment and the science in between

(2016) Chandrani Chattopadhyay et al.   CANCER

Clinical outcomes in metastatic uveal melanoma treated with PD-1 and PD-L1 antibodies

(2016) Alain P. Algazi et al.   CANCER

Dual Faces of IFN  in Cancer Progression: A Role of PD-L1 Induction in the Determination of Pro- and Antitumor Immunity

(2016) M. Mandai et al.   CLINICAL CANCER RESEARCH

Upregulation of HLA Expression in Primary Uveal Melanoma by Infiltrating Leukocytes

(2016) T. Huibertus van Essen et al.   PLoS One

Identification of an Immunogenic Subset of Metastatic Uveal Melanoma

(2015) L. D. Rothermel et al.   CLINICAL CANCER RESEARCH

Characterization of the human α9 integrin subunit gene: Promoter analysis and transcriptional regulation in ocular cells

(2015) Céline Duval et al.   EXPERIMENTAL EYE RESEARCH

Ocular Immune Privilege and Ocular Melanoma: Parallel Universes or Immunological Plagiarism?

(2012) Jerry Y. Niederkorn   Frontiers in Immunology

Influence of Immune Privilege on Ocular Tumor Development

(2010) Kyle C. McKenna et al.   OCULAR IMMUNOLOGY AND INFLAMMATION